FDA — authorised 29 December 1993
- Application: BLA020304
- Marketing authorisation holder: BAYER HLTHCARE
- Local brand name: TRASYLOL
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Trasylol in United States
FDA authorised Trasylol on 29 December 1993
Marketing authorisations
FDA
- Status: approved
Trasylol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Trasylol approved in United States?
Yes. FDA authorised it on 29 December 1993; FDA has authorised it.
Who is the marketing authorisation holder for Trasylol in United States?
BAYER HLTHCARE holds the US marketing authorisation.